Online:
Visits:
Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Global Viscosupplementation Market Trends, Opportunity Analysis, Application and Forecast 2016-2022

Monday, January 9, 2017 23:50
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Viscosupplementation is the latest treatment which is being rapidly adapted these days for the treatment of osteoarthritis. It is a method of injecting hyaluronic acid in stiff joints specially knees. Due to the global adoption, the Viscosupplementation market is expected to hit $1756 million during 2015-2021 growing at an impressive CAGR of 6% during the forecast period. The main reason behind a solid growth of Viscosupplementation market on the global level is the rapid rise in the elderly population suffering from osteoarthritis. This elderly population is expected to increase in future due to advancement in the healthcare facilities which would ultimately require Disco supplementation for patients suffering from osteoarthritis during the forecast period. 

 For more information http://www.reportsweb.com/viscosupplementation-global-analysis-and-market-insights-opportunity-analysis-market-shares-and-forecast-2016-2022 .

Further, Intra-articular Viscosupplementation with hyaluronic acid (HA) is gaining a good acceptance as a therapeutic alternative to knee replacement surgery in OA in the past decade. North America is expected to be the largest market for Viscosupplementation during the forecast period in which the US being the major contributor to the global market for Viscosupplementation. On the flip side, APAC is seeing good growth in demand for Viscosupplementation fluids due to rising cases of osteoarthritis in countries such as India and China. However, the growing concern of physicians who updated American Academy of Orthopedic Surgeons (AAOS) and Osteoarthritis Research Society International (OARSI) treatment guidelines for knee OA will affect in rising insurance denials for Viscosupplementation. Further the price competition and product differentiation are some of the factors that can restrict the smooth growth of the market during the forecast period.

Request Sample Copy http://www.reportsweb.com/inquiry&RW0001329451/sample .

Companies Mentioned: -

1. AJINOMOTO COMPANY INCORPORATION
2. AB ENZYMES
3. BASF SE
4. AMANO ENZYME INC
5. THE DOW CHEMICAL COMPANY
6. ARCHER DANIELS MIDLAND COMPANY
7. NOVOZYMES A/S
8. CARGILL INCORPORATION.
9. EVONIK INDUSTRIES AG
10. DU PONT DANISCO A/S
11. DSM
12. CHR
13. FUSO CHEMICAL
14. HOFFMANN-LA ROCHE
15. AMINO

Make an enquiry: http://www.reportsweb.com/inquiry&RW0001329451/buying .

Contact Us:

Call: +1-646-491-9876
Email: sales@reportsweb.com

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories
 

Featured

 

Top Global

 

Top Alternative

 

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.